Deal snapshot: Fujirebio to Acquire Neurodegenerative Biomarkers Developer ADx Neurosciences.

MANews-(C)2009-2022

Japan-based healthcare group H.U. Group Holdings Inc's Fujirebio Holdings, Inc subsidiary has agreed to acquire Belgian neurodegenerative biomarkers developer ADx NeuroSciences NV for EUR 40m (USD 42.10m), the group said.

Pending the satisfaction of customary closing conditions, the deal is expected to close in July 2022. ADx NeuroSciences becomes a wholly...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT